Yu-Juei Hsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu-Juei Hsu has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
Shih-Hua Lin
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.
4 shared publications- Chen-Liang Tsai
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
3 shared publications - Chih-Yuan Lin
Division of Cardiovascular Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
3 shared publications Ann Chen
¶Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
2 shared publicationsChen Wei Lin
School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, Republic of China
2 shared publications- Cheng-Chin Kuo
Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan
2 shared publications
Latest Publications
- 30 October 2026
- Published by Wiley in Therapeutic Apheresis and Dialysis
Voluntary ChatGPT Query Sharing With Nurse Feedback and Serum Phosphorus in Peritoneal Dialysis Patients
Introduction: This study examined whether voluntary ChatGPT query sharing with nurse feedback was associated with serum phosphorus in patients receiving peritoneal dialysis (PD). Methods: In this prospective longitudinal study, eighty‐eight patients completed a 3‐month program (T1–T3) and 2‐month follow‐up. Twenty shared ChatGPT query screenshots with nurses via LINE and received feedback. Linear mixed‐effects models examined serum phosphorus and the ratio relative to the 12‐month pre‐program mean (PR‐P12M). Results: Query sharing was associated with lower serum phosphorus across 5 months ( p = 0.025), without a significant group × time interaction. Sidak‐adjusted month‐specific comparisons showed lower serum phosphorus at T2 (mean difference = 0.687 mg/dL; 95% CI, 0.199–1.174; p = 0.006). PR‐P12M was similarly associated with query sharing ( p = 0.008), without a significant group × time interaction. Conclusion: Voluntary ChatGPT query sharing with nurse feedback was associated with lower serum phosphorus, suggesting a potential role for AI‐assisted dietary information seeking within nurse‐guided phosphorus education in PD care.
- 30 October 2026
- Published by Wiley in Therapeutic Apheresis and Dialysis
Voluntary ChatGPT Query Sharing With Nurse Feedback and Serum Phosphorus in Peritoneal Dialysis Patients
Introduction: This study examined whether voluntary ChatGPT query sharing with nurse feedback was associated with serum phosphorus in patients receiving peritoneal dialysis (PD). Methods: In this prospective longitudinal study, eighty‐eight patients completed a 3‐month program (T1–T3) and 2‐month follow‐up. Twenty shared ChatGPT query screenshots with nurses via LINE and received feedback. Linear mixed‐effects models examined serum phosphorus and the ratio relative to the 12‐month pre‐program mean (PR‐P12M). Results: Query sharing was associated with lower serum phosphorus across 5 months ( p = 0.025), without a significant group × time interaction. Sidak‐adjusted month‐specific comparisons showed lower serum phosphorus at T2 (mean difference = 0.687 mg/dL; 95% CI, 0.199–1.174; p = 0.006). PR‐P12M was similarly associated with query sharing ( p = 0.008), without a significant group × time interaction. Conclusion: Voluntary ChatGPT query sharing with nurse feedback was associated with lower serum phosphorus, suggesting a potential role for AI‐assisted dietary information seeking within nurse‐guided phosphorus education in PD care.
- 28 July 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 107
Hypercalcemia unmasks a PTHrP-secreting liver metastasis in papillary thyroid carcinoma
- 28 July 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 107
Hypercalcemia unmasks a PTHrP-secreting liver metastasis in papillary thyroid carcinoma
- Open Access
- 4 June 2026
- Published by Wiley in Aging Cell
- Vol. 25 (6) , e70578
Magnesium as a Bioenergetic Checkpoint Linking Mitochondrial Function, Metabolic Disease, and Aging
Magnesium is traditionally viewed as a permissive electrolyte required for cellular viability. Emerging evidence, however, reveals a more central role for Mg 2+ as an active regulator of mitochondrial bioenergetics and metabolic resilience. In this Review, we synthesize recent advances in renal magnesium handling, mitochondrial Mg 2+ transport, and MgATP chemistry to propose a unifying framework in which magnesium functions as a bioenergetic checkpoint. At the cellular level, Mg 2+ availability specifies the functional pool of ATP, constrains kinase signaling, and stabilizes mitochondrial performance by limiting calcium overload and oxidative stress. At the tissue and organismal levels, disruption of magnesium homeostasis contributes to metabolic inflexibility, insulin resistance, acute kidney injury, and the progressive decline in stress tolerance that accompanies aging. We further discuss how age‐associated drift in mitochondrial magnesium may act as a hidden temporal regulator that lowers the threshold for cellular senescence. Finally, we outline emerging therapeutic strategies, including transport‐informed and compartment‐specific approaches, that move beyond nonspecific supplementation toward precision modulation of magnesium‐dependent bioenergetics. Together, this framework positions magnesium as a mechanistic link between mitochondrial function, metabolic disease, and aging, with broad implications for translational intervention.
- 4 June 2026
- Published by Wiley in Aging Cell
- Vol. 25 (6) , e70578
Open AccessMagnesium as a Bioenergetic Checkpoint Linking Mitochondrial Function, Metabolic Disease, and Aging
Magnesium is traditionally viewed as a permissive electrolyte required for cellular viability. Emerging evidence, however, reveals a more central role for Mg 2+ as an active regulator of mitochondrial bioenergetics and metabolic resilience. In this Review, we synthesize recent advances in renal magnesium handling, mitochondrial Mg 2+ transport, and MgATP chemistry to propose a unifying framework in which magnesium functions as a bioenergetic checkpoint. At the cellular level, Mg 2+ availability specifies the functional pool of ATP, constrains kinase signaling, and stabilizes mitochondrial performance by limiting calcium overload and oxidative stress. At the tissue and organismal levels, disruption of magnesium homeostasis contributes to metabolic inflexibility, insulin resistance, acute kidney injury, and the progressive decline in stress tolerance that accompanies aging. We further discuss how age‐associated drift in mitochondrial magnesium may act as a hidden temporal regulator that lowers the threshold for cellular senescence. Finally, we outline emerging therapeutic strategies, including transport‐informed and compartment‐specific approaches, that move beyond nonspecific supplementation toward precision modulation of magnesium‐dependent bioenergetics. Together, this framework positions magnesium as a mechanistic link between mitochondrial function, metabolic disease, and aging, with broad implications for translational intervention.
- Open Access
- 9 August 2025
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 20 (1) , 112
Femoral artery calcification predicts hip fracture in maintenance hemodialysis patients
Summary: Femoral artery calcification (FAC) is a significant predictor of hip fractures in hemodialysis patients. A higher FAC score is associated with increased fracture risk and poor survival outcomes. Identifying FAC through radiographic assessment may improve fracture risk stratification and clinical management in this high-risk population. Purpose: Patients with end-stage renal disease (ESRD) on hemodialysis (HD) are at increased risk for vascular calcification (VC) and bone fractures. While previous studies have linked aortic calcification with hip fractures, the relationship between medium-caliber artery-femoral artery calcification (FAC) and fall-related hip fractures in HD patients remains unclear. Methods: We retrospectively analyzed 170 HD patients who experienced falls and sought treatment in the emergency department (ED) between 2007 and 2014. The FAC score, representing the severity of femoral artery calcification, was calculated as the ratio of the total length of calcification plaques to the length of the femoral vessel visible on plain radiographs of the hip and femur. A logistic regression model assessed the association between FAC score and hip fracture risk, and receiver operating characteristic curve analysis evaluated its predictive power. Results: Among the 130 patients meeting inclusion criteria, 55 had fall-related hip fractures. The incidence rate of hip fractures among dialysis patients was 6.18 cases per 1000 person-years by dividing the total number of hip fracture events by the cumulative dialysis duration (in years) of all enrolled patients. Fracture patients were older and had lower serum creatinine, sodium, and albumin levels but higher aspartate aminotransferase levels. The fracture group also had a higher FAC score (0.47 [IQR, 0.28 – 0.76] vs. 0.00 [IQR, 0.00 – 0.40], p < 0.001). Multivariable analysis identified old age, heart failure with reduced ejection fraction (EF), and higher FAC scores as independent risk factors for hip fractures. Survival curves showed increased mortality among patients with higher FAC scores and hip fractures ( p < 0.01). Conclusion. High FAC scores were associated with an increased risk of hip fractures in HD patients, independent of traditional risk factors, and were linked to poor survival outcomes.
- 9 August 2025
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 20 (1) , 112
Open AccessFemoral artery calcification predicts hip fracture in maintenance hemodialysis patients
Summary: Femoral artery calcification (FAC) is a significant predictor of hip fractures in hemodialysis patients. A higher FAC score is associated with increased fracture risk and poor survival outcomes. Identifying FAC through radiographic assessment may improve fracture risk stratification and clinical management in this high-risk population. Purpose: Patients with end-stage renal disease (ESRD) on hemodialysis (HD) are at increased risk for vascular calcification (VC) and bone fractures. While previous studies have linked aortic calcification with hip fractures, the relationship between medium-caliber artery-femoral artery calcification (FAC) and fall-related hip fractures in HD patients remains unclear. Methods: We retrospectively analyzed 170 HD patients who experienced falls and sought treatment in the emergency department (ED) between 2007 and 2014. The FAC score, representing the severity of femoral artery calcification, was calculated as the ratio of the total length of calcification plaques to the length of the femoral vessel visible on plain radiographs of the hip and femur. A logistic regression model assessed the association between FAC score and hip fracture risk, and receiver operating characteristic curve analysis evaluated its predictive power. Results: Among the 130 patients meeting inclusion criteria, 55 had fall-related hip fractures. The incidence rate of hip fractures among dialysis patients was 6.18 cases per 1000 person-years by dividing the total number of hip fracture events by the cumulative dialysis duration (in years) of all enrolled patients. Fracture patients were older and had lower serum creatinine, sodium, and albumin levels but higher aspartate aminotransferase levels. The fracture group also had a higher FAC score (0.47 [IQR, 0.28 – 0.76] vs. 0.00 [IQR, 0.00 – 0.40], p < 0.001). Multivariable analysis identified old age, heart failure with reduced ejection fraction (EF), and higher FAC scores as independent risk factors for hip fractures. Survival curves showed increased mortality among patients with higher FAC scores and hip fractures ( p < 0.01). Conclusion. High FAC scores were associated with an increased risk of hip fractures in HD patients, independent of traditional risk factors, and were linked to poor survival outcomes.
- Open Access
- 19 November 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (22) , e035044
Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling
Background: Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular events. However, the precise mechanisms beyond glycemic control are not fully understood. The objective of this study was to determine the role of PDGF (platelet‐derived growth factor)–related signaling in empagliflozin‐mediated inhibition of neointima formation. Methods and Results: Adult male nondiabetic Wistar rats were subjected to carotid artery balloon injury. Empagliflozin (30 mg/kg per day) was administered by oral gavage for 18 days beginning 4 days before surgery. The in vitro effects of empagliflozin on rat aortic vascular smooth muscle cell (VSMC) proliferation and migration were also determined. Empagliflozin attenuated balloon injury–induced neointima formation in carotid arteries. In VSMCs, empagliflozin attenuated PDGF‐BB‐induced proliferation and migration. Moreover, empagliflozin‐treated VSMCs did not undergo apoptosis or cytotoxic death. Empagliflozin suppressed PDGF‐related signaling, including phosphorylation of PDGF receptor β, Akt, and STAT3 (signal transducer and activator of transcription 3). Overactivation of PDGF signaling attenuated empagliflozin‐mediated inhibition of VSMC function. SGLT2 mRNA levels in rat VSMCs were undetectable, and SGLT2 silencing did not alter the empagliflozin‐mediated effects, supporting the SGLT2‐independent effects of empagliflozin on VSMC. Conclusions: This study highlights the crucial role of suppressing PDGF‐related signaling in mediating the beneficial effects of empagliflozin on neointima formation and VSMC function, which are independent of SGLT2 and glycemic control. Our study provides a novel mechanistic aspect of empagliflozin for the prevention of vascular stenosis disorders.
- 19 November 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (22) , e035044
Open AccessEmpagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling
Background: Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular events. However, the precise mechanisms beyond glycemic control are not fully understood. The objective of this study was to determine the role of PDGF (platelet‐derived growth factor)–related signaling in empagliflozin‐mediated inhibition of neointima formation. Methods and Results: Adult male nondiabetic Wistar rats were subjected to carotid artery balloon injury. Empagliflozin (30 mg/kg per day) was administered by oral gavage for 18 days beginning 4 days before surgery. The in vitro effects of empagliflozin on rat aortic vascular smooth muscle cell (VSMC) proliferation and migration were also determined. Empagliflozin attenuated balloon injury–induced neointima formation in carotid arteries. In VSMCs, empagliflozin attenuated PDGF‐BB‐induced proliferation and migration. Moreover, empagliflozin‐treated VSMCs did not undergo apoptosis or cytotoxic death. Empagliflozin suppressed PDGF‐related signaling, including phosphorylation of PDGF receptor β, Akt, and STAT3 (signal transducer and activator of transcription 3). Overactivation of PDGF signaling attenuated empagliflozin‐mediated inhibition of VSMC function. SGLT2 mRNA levels in rat VSMCs were undetectable, and SGLT2 silencing did not alter the empagliflozin‐mediated effects, supporting the SGLT2‐independent effects of empagliflozin on VSMC. Conclusions: This study highlights the crucial role of suppressing PDGF‐related signaling in mediating the beneficial effects of empagliflozin on neointima formation and VSMC function, which are independent of SGLT2 and glycemic control. Our study provides a novel mechanistic aspect of empagliflozin for the prevention of vascular stenosis disorders.
- Open Access
- 30 October 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (24) , 41462-41473
A Cross-Modal Autoencoder for Contactless Electrocardiography Monitoring Using Frequency-Modulated Continuous Wave Radar
While traditional electrocardiogram (ECG) monitoring provides vital clinical information, its electrode-based setup restricts patient movement. To address this limitation, contactless ECG monitoring using frequency-modulated continuous-wave (FMCW) radar and deep learning have been developed. However, such approaches face challenges owing to the limited availability of training data and inherent discrepancies between radar and ECG signals. This paper introduces a novel approach to transforming high-fidelity ECG signals from millimeter-wave (mmWave) radar signals reflecting cardiac mechanical activity. The proposed method uses a cascade framework with a cross-modal autoencoder trained using joint waveforms, spectrograms, and deep feature losses. This strategy enables the model to leverage a pre-trained ECG-to-ECG autoencoder and cardiac event predictor for learning general ECG representations while simultaneously capturing time- and frequency-domain features from limited data. We evaluated the effectiveness of the proposed autoencoder model in terms of the signal quality and cardiac event integrity using ablation studies on data from 20 healthy participants. The model achieved high transformation accuracy with a cross-correlation of 0.914 and average timing errors below 31 ms for critical ECG features. These findings demonstrate the feasibility and effectiveness of the proposed FMCW radar-based contactless ECG monitoring method, particularly in overcoming the limitations imposed by small datasets and domain discrepancies.
- 30 October 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 24 (24) , 41462-41473
Open AccessA Cross-Modal Autoencoder for Contactless Electrocardiography Monitoring Using Frequency-Modulated Continuous Wave Radar
While traditional electrocardiogram (ECG) monitoring provides vital clinical information, its electrode-based setup restricts patient movement. To address this limitation, contactless ECG monitoring using frequency-modulated continuous-wave (FMCW) radar and deep learning have been developed. However, such approaches face challenges owing to the limited availability of training data and inherent discrepancies between radar and ECG signals. This paper introduces a novel approach to transforming high-fidelity ECG signals from millimeter-wave (mmWave) radar signals reflecting cardiac mechanical activity. The proposed method uses a cascade framework with a cross-modal autoencoder trained using joint waveforms, spectrograms, and deep feature losses. This strategy enables the model to leverage a pre-trained ECG-to-ECG autoencoder and cardiac event predictor for learning general ECG representations while simultaneously capturing time- and frequency-domain features from limited data. We evaluated the effectiveness of the proposed autoencoder model in terms of the signal quality and cardiac event integrity using ablation studies on data from 20 healthy participants. The model achieved high transformation accuracy with a cross-correlation of 0.914 and average timing errors below 31 ms for critical ECG features. These findings demonstrate the feasibility and effectiveness of the proposed FMCW radar-based contactless ECG monitoring method, particularly in overcoming the limitations imposed by small datasets and domain discrepancies.
- Open Access
- 26 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (7) , 3972
Correlation between Physical Activity and Psychological Distress in Patients Receiving Hemodialysis with Comorbidities: A Cross-Sectional Study
Comorbidities cause psychological distress to patients on hemodialysis and cause their physical function to deteriorate. This study aims to examine whether physical patterns are associated with anxiety, depression and fatigue among patients with and without comorbidities who are on hemodialysis. To this end, a cross-sectional survey was administered to 120 patients on hemodialysis. Data were collected using the International Physical Activity Questionnaire—Short Form, Beck Depression Inventory—Second Edition, Beck Anxiety Inventory, and Brief Fatigue Inventory—Taiwan Version. An independent sample t test and generalized linear model analyses were conducted. The results revealed that patients with comorbidities exhibited more severe levels of depression (p < 0.001), anxiety (p < 0.001), and fatigue (p = 0.010) than patients without comorbidities. Additionally, patients on hemodialysis with a high physical activity level (≥600 metabolic equivalent of task per min/week) exhibited less depression (B = −4.03; p < 0.001; 95% confidence interval [CI] = −6.04, −2.03) and anxiety (B = −2.64; p = 0.002; 95% CI = −4.27, −1.00) severity than those with a low physical activity level; those who engaged in weekly physical activities exhibited less fatigue severity (B = −1.17; p = 0.001; 95% CI = −1.84, −0.49) and fatigue interference (B = −0.61; p = 0.015; 95% CI = −1.10, −0.12). For patients on hemodialysis, having comorbidities was correlated with more severe levels of depression, anxiety, and fatigue. Weekly moderate-intensity physical activities were revealed to be correlated with less severity levels of depression, anxiety, and fatigue. The study findings aid the development of interventions for promoting physical activity among patients on hemodialysis to prevent the exacerbation of complications caused by comorbidities and psychological distress.
- 26 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (7) , 3972
Open AccessCorrelation between Physical Activity and Psychological Distress in Patients Receiving Hemodialysis with Comorbidities: A Cross-Sectional Study
Comorbidities cause psychological distress to patients on hemodialysis and cause their physical function to deteriorate. This study aims to examine whether physical patterns are associated with anxiety, depression and fatigue among patients with and without comorbidities who are on hemodialysis. To this end, a cross-sectional survey was administered to 120 patients on hemodialysis. Data were collected using the International Physical Activity Questionnaire—Short Form, Beck Depression Inventory—Second Edition, Beck Anxiety Inventory, and Brief Fatigue Inventory—Taiwan Version. An independent sample t test and generalized linear model analyses were conducted. The results revealed that patients with comorbidities exhibited more severe levels of depression (p < 0.001), anxiety (p < 0.001), and fatigue (p = 0.010) than patients without comorbidities. Additionally, patients on hemodialysis with a high physical activity level (≥600 metabolic equivalent of task per min/week) exhibited less depression (B = −4.03; p < 0.001; 95% confidence interval [CI] = −6.04, −2.03) and anxiety (B = −2.64; p = 0.002; 95% CI = −4.27, −1.00) severity than those with a low physical activity level; those who engaged in weekly physical activities exhibited less fatigue severity (B = −1.17; p = 0.001; 95% CI = −1.84, −0.49) and fatigue interference (B = −0.61; p = 0.015; 95% CI = −1.10, −0.12). For patients on hemodialysis, having comorbidities was correlated with more severe levels of depression, anxiety, and fatigue. Weekly moderate-intensity physical activities were revealed to be correlated with less severity levels of depression, anxiety, and fatigue. The study findings aid the development of interventions for promoting physical activity among patients on hemodialysis to prevent the exacerbation of complications caused by comorbidities and psychological distress.
- Open Access
- 1 February 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121, S12-S19
Mortality rate of end-stage kidney disease patients in Taiwan
- 1 February 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121, S12-S19
Open AccessMortality rate of end-stage kidney disease patients in Taiwan
- Open Access
- 12 January 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (2) , 811
Physical Activity and Health-Related Quality of Life of Patients on Hemodialysis with Comorbidities: A Cross-Sectional Study
Patients on hemodialysis with multiple comorbidities have limited physical activity, resulting in poor health, low activity participation, and low quality of life. Accordingly, the nursing care provided to such patients should include regular physical activity training programs. Therefore, this cross-sectional descriptive study investigated whether patients on hemodialysis with and without comorbidities have different levels of physical activity and health-related quality of life (HRQoL); the correlations among the comorbidities, physical activity, and HRQoL of the two cohorts were also assessed. The 36-Item Short-Form Health Survey version 2 and International Physical Activity Questionnaire were employed to collect data from 120 patients on hemodialysis. An independent samples t-test and univariate and multivariate linear regression analyses were conducted. The overall HRQoL of patients with comorbidities was lower than that of patients without comorbidities (p = 0.008). Compared with patients who participated in low-intensity physical activity, the overall HRQoL of patients who participated in moderate-intensity physical activity was higher (p < 0.001). The overall HRQoL of patients with comorbidities who participated in low-intensity physical activity was lower than that of those who participated in moderate-intensity physical activity (p < 0.001). Moderate-intensity physical activity was correlated with higher HRQoL for patients with comorbidities. This finding supports the implementation of effective physical activity intervention measures. Furthermore, it supports the promotion of patient self-management and the implementation of regular exercise programs and lifestyle changes, and patients on hemodialysis can benefit from the future management of physical activities.
- 12 January 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (2) , 811
Open AccessPhysical Activity and Health-Related Quality of Life of Patients on Hemodialysis with Comorbidities: A Cross-Sectional Study
Patients on hemodialysis with multiple comorbidities have limited physical activity, resulting in poor health, low activity participation, and low quality of life. Accordingly, the nursing care provided to such patients should include regular physical activity training programs. Therefore, this cross-sectional descriptive study investigated whether patients on hemodialysis with and without comorbidities have different levels of physical activity and health-related quality of life (HRQoL); the correlations among the comorbidities, physical activity, and HRQoL of the two cohorts were also assessed. The 36-Item Short-Form Health Survey version 2 and International Physical Activity Questionnaire were employed to collect data from 120 patients on hemodialysis. An independent samples t-test and univariate and multivariate linear regression analyses were conducted. The overall HRQoL of patients with comorbidities was lower than that of patients without comorbidities (p = 0.008). Compared with patients who participated in low-intensity physical activity, the overall HRQoL of patients who participated in moderate-intensity physical activity was higher (p < 0.001). The overall HRQoL of patients with comorbidities who participated in low-intensity physical activity was lower than that of those who participated in moderate-intensity physical activity (p < 0.001). Moderate-intensity physical activity was correlated with higher HRQoL for patients with comorbidities. This finding supports the implementation of effective physical activity intervention measures. Furthermore, it supports the promotion of patient self-management and the implementation of regular exercise programs and lifestyle changes, and patients on hemodialysis can benefit from the future management of physical activities.
- Open Access
- 21 December 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 27, 656-669
miR-424/322 protects against abdominal aortic aneurysm formation by modulating the Smad2/3/runt-related transcription factor 2 axis
- 21 December 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 27, 656-669
Open AccessmiR-424/322 protects against abdominal aortic aneurysm formation by modulating the Smad2/3/runt-related transcription factor 2 axis